AbbVie Picks Up Dong-A Candidate As It Makes Immuno-Onc Inroads

 
• By Jung Won Shin

Dong-A ST has scored a major early success in its inroads into cancer R&D through a sizable immuno-oncology deal with AbbVie, which also underscores the US firm’s push to expand its assets in the area.

businessman and businesswoman are shaking hands and exchanging folder after agreement was reached

More from Business

More from Scrip